quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·1414d
PRRelease
Isleworth Healthcare Acquisition Corporation logo

Cytovia Therapeutics presents antitumor activity of its CD38-Targeting Flex-NK™ Cell Engager antibody at EHA 2022 Congress

ISLE· Isleworth Healthcare Acquisition Corporation
Industrials
Original source

Companies

  • ISLE
    Isleworth Healthcare Acquisition Corporation
    Industrials

Related

  • SEC1322d
    SEC Form 15-12G filed by Isleworth Healthcare Acquisition Corporation
  • SEC1336d
    SEC Form 25-NSE filed by Isleworth Healthcare Acquisition Corporation
  • SEC1336d
    Isleworth Healthcare Acquisition Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • PR1337d
    Isleworth Healthcare Acquisition Corp. Announces Cancellation of Special Meeting of Shareholders, Redemption of Public Shares and Subsequent Dissolution
  • SEC1350d
    SEC Form 10-Q filed by Isleworth Healthcare Acquisition Corporation
  • SEC1359d
    SEC Form DEF 14A filed by Isleworth Healthcare Acquisition Corporation
  • SEC1375d
    SEC Form PRE 14A filed by Isleworth Healthcare Acquisition Corporation
  • PR1393d
    ISLEWORTH AND CYTOVIA TERMINATE MERGER AGREEMENT
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022